From Insight to Impact: Strategic Growth Mapping in the Hospital-Acquired Infection Control Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Hospital-Acquired Infection Control Market Growth Performance Trended Historically, And What Lies Ahead?
There has been a consistent growth in the market size of hospital-acquired infection control over the past years. The size of the market is predicted to increase from $34.59 billion in 2024 to $35.75 billion in 2025, with a compound annual growth rate (CAGR) of 3.4%. The historic growth can be linked to factors such as a growing resistance to antibiotics, increased awareness, strict regulations, the global spread of infectious diseases, and initiatives towards patient safety.
The market size of hospital-acquired infection control is anticipated to exhibit remarkable growth in the upcoming years. The market is projected to reach $44.06 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this growth during the forecast period include the emergence of multidrug-resistant pathogens, pandemic readiness, enhanced surveillance and monitoring, antimicrobial stewardship efforts, and international cooperation. Notable trends shaping the forecast period are the use of real-time location systems (RTLS), the inclusion of artificial intelligence (AI) in surveillance, a shift towards single-use and disposable devices, a strong focus on staff training and instruction, and an increased use of disinfection technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp
What are the Fundamental Drivers and Innovations Shaping the Hospital-Acquired Infection Control Market?
The hospital-acquired infection control market is projected to expand due to the rise in COVID-19 incidences. COVID-19 is a viral infection brought about by the SARS-CoV-2 virus. With the onset of the COVID-19 pandemic, there has been a surge in the need for hospital-acquired infection control goods and services, with an emphasis on personal cleanliness and the manufacture of infection control medical equipment. For example, World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that global COVID-19 cases hit 581.6 million on 8th August 2022. Consequently, the climbing numbers of COVID-19 cases are fueling the growth of the hospital-acquired infection control market.
How Is the Hospital-Acquired Infection Control Market Segmented?
The hospital-acquired infection controlmarket covered in this report is segmented –
1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products
2) By Technology: Phenotypic Methods; Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
4) By Application: Disease Testing; Drug-Resistance Testing
5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers; Ethylene Oxide Sterilizers; Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors; Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors; Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems; Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps; Filters; Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants; Chlorine-based Disinfectants; Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions; Data Management Software
8) By Other Products: Cleaning Equipment; Air Purification Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp
Which Regions Are Driving the Next Phase of the Hospital-Acquired Infection Control Market Growth?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Hospital-Acquired Infection Control Market?
Leading businesses in the hospital-acquired infection control market are concentrating on creating novel tech solutions such as artificial intelligence systems for early sepsis detection to improve patient results by enabling prompt diagnosis and therapy. This AI-based sepsis detection system leverages advanced technology using AI and machine learning algorithms to recognize initial sepsis indicators in patients. For example, in April 2024, US-based medical clinic Prenosis Inc. was granted FDA marketing approval for Sepsis ImmunoScore, the first AI-powered system specifically designed to foresee sepsis, a potentially fatal condition that can result in extreme complications. This path-breaking device boosts early detection via real-time data evaluation, empowering healthcare practitioners to act more swiftly and efficaciously. The employment of AI is designed to assist rather than substitute medical personnel in decision-making, ultimately enhancing patient results and cutting healthcare expenses.
View the full report here:
How Is the Hospital-Acquired Infection Control Market Defined and What Are Its Core Parameters?
Hospital-acquired infections are acquired during hospital care that is not present before hospital admission. The prevention and control of hospital-acquired infection using various cleaning, sterilization, and disinfection methods refers to hospital-acquired infection control. These infections can be caused by the cross-infection from the surfaces of equipment, the skin of patients, and healthcare staff. Hospital-acquired infection control is used to reduce or eliminate the transmission of illnesses.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7694
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
